To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
USA115th CongressHR-4408| House
| Updated: 12/13/2017
John Katko
Republican Representative
New York
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Crime and Law Enforcement
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs
To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
USA115th CongressHR-4408| House
| Updated: 12/13/2017
Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
John Katko
Republican Representative
New York
Cosponsors (1)
Crime and Federal Government Surveillance Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee
Crime and Law Enforcement
Related Bills
- HR 115-4482: To deter opioid abuse and addiction, to establish additional registration requirements for prescribers of opioids, to encourage the development of abuse-deterrent formulations, to require a study and report on policy changes that may have contributed to the opioid epidemic, and for other purposes.
- S 115-892: A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
- HR 115-3964: To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesHealth personnelLicensing and registrationsPrescription drugs